Proteogenomic Platform for Identification of Tumor Specific Antigens
نویسندگان
چکیده
منابع مشابه
Human tumor antigens and specific tumor therapy.
In what case do you like reading so much? What about the type of the human tumor antigens and specific tumor therapy book? The needs to read? Well, everybody has their own reason why should read some books. Mostly, it will relate to their necessity to get knowledge from the book and want to read just to get entertainment. Novels, story book, and other entertaining books become so popular this d...
متن کاملTumor-specific Antigens of Putatively Nonviral Tumors1
anisms of the animals in which the neoplasms originate. Al most all of the putatively nonviral tumors are individually specific and few, if any, cross-reactions occur among them. The antigenic titer varies greatly and is related to the latent period and the immunologie reactivity of the tumor host. This rela tionship is almost certainly due to immunoselection. The an tigens are found in early p...
متن کاملIdentification of tumor antigens in malignant mesothelioma
Serological analysis of recombinant tumor cDNA expression library (SEREX) is a powerful and widely used method to explore the cancer immune environment. In the present study, immunoscreening of normal testicular tissues and malignant mesothelioma (MM) cancer MSTO-211H cell line cDNA libraries with sera from 5 MM patients led to the isolation of 16 independent antigens, which were designated 'Ko...
متن کاملIdentification of placental-specific antigens in ruminants
© 1998 Journals of Reproduction and Fertility 1359-6004/98 $12.50 The placentation that occurs in ruminant ungulate species, such as cattle, sheep and goats, is superficial, relatively noninvasive, and can be referred to as synepitheliochorial cotyledonary (Wooding, 1992). ‘Synepitheliochorial’ describes the fetal– maternal syncytium formed by the fusion of trophoblast binucleate cells and uter...
متن کاملTumor-Associated Antigens for Specific Immunotherapy of Prostate Cancer
Prostate cancer (PCa) is the most common noncutaneous cancer diagnosis and the second leading cause of cancer-related deaths among men in the United States. Effective treatment modalities for advanced metastatic PCa are limited. Immunotherapeutic strategies based on T cells and antibodies represent interesting approaches to prevent progression from localized to advanced PCa and to improve survi...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Klinicka onkologie
سال: 2018
ISSN: 0862-495X,1802-5307
DOI: 10.14735/amko20182s102